Novel therascreen® FGFR RGQ RT-PCR Kit will aid in identifying patients eligible for treatment with BALVERSA™ (erdafitinib), developed by Janssen.

NeuMoDx plans to deliver 11 CE-IVD assays to QIAGEN by the end of 2019 on NeuMoDx System as part of aggressive menu expansion plans, including blood-borne viruses, women’s health and transplantation assays.

Dedicated show for UK laboratory industry recognised by Exhibition News Awards for exceptional visitor and exhibitor growth and satisfaction.

AMSBIO announces XerumFree™ - a new concept in cell culture that allows you to culture cells without the use of serum.

SP Scientific conducted a video interview with Dr Kevin Ward of Biopharma Process Systems Ltd to discuss how expanding design space increases the probability of executing a successful lyophilization cycle.

This new range of recombinant monoclonal antibodies, directed against the three main mouse isotypes: IgG1, IgG2a, and IgG2b, offer improved signal detection and specificity in imaging, ELISA, flow cytometry, and western blotting.

Thermo Fisher and Genovis to develop advanced end-to-end workflows for biotherapeutics analysis.

They will be targeting customers in industries such as Pharmaceutical, Environmental, Food & Water Testing, Veterinary, Petrochemical and Large Biobanks (where they supply automated systems).

At the 60th Experimental Nuclear Magnetic Resonance Conference (ENC, www.enc-conference.org ), Bruker announced a breakthrough in ultra-high field (UHF) high-resolution NMR spectroscopy applied to structural biology and the study of functional intrinsically disordered proteins (IDPs).

Sales increase by 5.6% to €729.2 million (8.2% in local currencies).